Frequency News and Research

RSS

Mammography screening can benefit women under age 50

Screening mammography benefits women between 40 and 49 years of age, and excluding this population from annual exams under the revised Preventative Service Task Force mammography guidelines would negatively impact survival, according to research presented this week at the American Society of Breast Surgeons Annual Meeting.

30 Apr 2011

3D models prove useful in neurosurgical planning

3D models, produced by combining a patient's CT scans and 3D printing technology are proving useful in neurosurgical planning.

30 Apr 2011

Early interventions can help cease smoking

Cigarette smoking is the leading cause of premature, preventable death in the United States. Each year smoking causes an average of 438,000 deaths from cancer, heart disease, stroke, and lung disease, according to the National Cancer Institute.

30 Apr 2011

Harvard Engineering School receives $100,000 grant to develop microbial-based cell phone charger

A project to use dirt-powered batteries to charge cell phones in Africa won a $100,000 grant from The Bill & Melinda Gates Foundation today.

29 Apr 2011

Takeda, Affymax announce additional peginesatide Phase 3 study results in dialysis patients

Affymax, Inc. and Takeda Pharmaceutical Company Limited, today announced results of additional analyses from two Phase 3 studies of the investigational agent, peginesatide in chronic renal failure patients on dialysis with anemia.

29 Apr 2011

Centocor Ortho Biotech receives FDA approval for Zytiga to treat prostate cancer

The U.S. Food and Drug Administration today approved Zytiga in combination with prednisone to treat patients with late-stage castration-resistant prostate cancer who have received prior docetaxel.

28 Apr 2011

FDA accepts OncoMed's IND filing for OMP-18R5 in Phase 1 clinical trial for advanced solid tumors

OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics that target cancer stem cells or tumor-initiating cells, today announced that the FDA has accepted an IND filing for OMP-18R5, which allows OncoMed to commence Phase 1 clinical testing.

28 Apr 2011

Positive results from Otonomy's OTO-104 Phase 1b study in Meniere's disease

Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced positive data from a Phase 1b study of the company's lead product candidate, OTO-104, in patients with Meniere's disease.

28 Apr 2011

Children, adolescents with liver disease may not benefit from vitamin E or metformin

In contrast to previous preliminary data, use of vitamin E or the diabetes drug metformin was not superior to placebo on a measured outcome for treating nonalcoholic fatty liver disease in children and adolescents, according to a study in the April 27 issue of JAMA.

27 Apr 2011

FDA supports new Hepatitis C drug from Vertex Pharmaceuticals

Vertex pharmaceuticals jumped 10 percent in value on the Nasdaq after U.S. regulators FDA said the company’s experimental hepatitis C drug cures more patients than current therapies.

26 Apr 2011

LCA-Vision reports first profitable quarter in three years

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, today announced financial and operational results for the three months ended March 31, 2011.

26 Apr 2011

Active Healthy Kids Canada releases 2011 Report Card on physical activity for children, youth

School's out, do you know what your kids are doing? You may want to think again if you believe they are being physically active.

26 Apr 2011

Merck receives Health Canada approval for GARDASIL to treat HPV in women upto age 45

Today, Merck announced that Health Canada has extended the indication of GARDASIL in women up to the age of 45. Merck's HPV vaccine is now approved for girls and women nine through 45 years of age for the prevention of cervical cancer, vulvar and vaginal cancers, precancerous lesions and genital warts caused by the Human Papillomavirus types 6, 11, 16, 18. Previously, GARDASIL was approved in girls and women nine through 26.

26 Apr 2011

Study: HIV infection linked to increased risk of heart failure

Patients with HIV infection without a prior history of coronary heart disease may be at a higher risk of developing heart failure, according to a report in the April 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

26 Apr 2011

Simple, obvious and obscure ways to keep minds sharp and brains healthy

From a glance at the magazine stands, Americans appear obsessed with losing weight, cutting their cardiac risks and seeking to improve their odds against cancer. But where's the focus on brain health?

25 Apr 2011

Uroplasty to present Urgent PC, Macroplastique products study data at upcoming meetings

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of clinical studies using Uroplasty's Urgent PC Neuromodulation System and Macroplastique urethral bulking agent products are scheduled to be presented at three upcoming professional meetings.

25 Apr 2011

LoJack announces availability of SafetyNet service in Miami-Dade County

LoJack SafetyNet, Inc., a wholly owned subsidiary of LoJack Corporation, today announced that its SafetyNet service is now available in Miami-Dade County.

25 Apr 2011

Echosens's Vibration Controlled Transient Elastography stands out at 46th EASL Congress

On the occasion of the 46th Congress of the European Association for the Study of the Liver, the VCTE(TM) (Vibration Controlled Transient Elastography) from Echosens stood out as a leading technique in the field. It is the only technique able to measure elasticity at a predetermined, controlled frequency (50 Hz), which is essential because elasticity increases as frequency increases.

22 Apr 2011

Mindfulness meditation may enhance mental abilities

The positive effects of mindfulness meditation on pain and working memory may result from an improved ability to regulate a crucial brain wave called the alpha rhythm.

22 Apr 2011

Using dietary supplements may lead to health-risk behaviors

Do you belong to the one-half of the population that frequently uses dietary supplements with the hope that it might be good for you?

22 Apr 2011

Frequency News and Research

Mammography screening can benefit women under age 50

3D models prove useful in neurosurgical planning

Early interventions can help cease smoking

Harvard Engineering School receives $100,000 grant to develop microbial-based cell phone charger

Takeda, Affymax announce additional peginesatide Phase 3 study results in dialysis patients

Centocor Ortho Biotech receives FDA approval for Zytiga to treat prostate cancer

FDA accepts OncoMed's IND filing for OMP-18R5 in Phase 1 clinical trial for advanced solid tumors

Positive results from Otonomy's OTO-104 Phase 1b study in Meniere's disease

Children, adolescents with liver disease may not benefit from vitamin E or metformin

FDA supports new Hepatitis C drug from Vertex Pharmaceuticals

LCA-Vision reports first profitable quarter in three years

Active Healthy Kids Canada releases 2011 Report Card on physical activity for children, youth

Merck receives Health Canada approval for GARDASIL to treat HPV in women upto age 45

Study: HIV infection linked to increased risk of heart failure

Simple, obvious and obscure ways to keep minds sharp and brains healthy

Uroplasty to present Urgent PC, Macroplastique products study data at upcoming meetings

LoJack announces availability of SafetyNet service in Miami-Dade County

Echosens's Vibration Controlled Transient Elastography stands out at 46th EASL Congress

Mindfulness meditation may enhance mental abilities

Using dietary supplements may lead to health-risk behaviors

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News